AJCN Tufts Nutrition Symposium, Boston Sept 24-26
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flaten, H.
Right arrow Articles by Osland, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flaten, H.
Right arrow Articles by Osland, A.
Agricola
Right arrow Articles by Flaten, H.
Right arrow Articles by Osland, A.

American Journal of Clinical Nutrition, Vol 52, 300-306, Copyright © 1990 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Fish-oil concentrate: effects on variables related to cardiovascular disease

H Flaten, AT Hostmark, P Kierulf, E Lystad, K Trygg, T Bjerkedal and A Osland
Occupational Health Office, Oslo Transport, Norway.

Sixty-four male, healthy volunteers aged 35-45 y were randomly assigned to receive (as 1-g capsules) either 14 g fish-oil concentrate/d (55% n- 3 fatty acids) or 14 g olive oil/d for 6 wk. Plasma fibrinogen was reduced by 13% and serum triglycerides by 22% after fish-oil supplementation ended. Three weeks after supplementation ended both variables were back to baseline values. An appreciable increase in the ratio of eicosapentaenoic acid to arachidonic acid (EPA:AA) in plasma eicosapentaenoic acid to arachidonic acid (EPA:AA) in plasma and red blood cell phospholipids occurred during the fish-oil intake. High- density-lipoprotein (HDL) cholesterol and HDL2 activity tended to be lowered by fish-oil supplementation. Systolic and diastolic blood pressures, serum cholesterol, gamma-glutamyltransferase, blood glucose, and monocyte low-density-lipoprotein receptor activity did not differ significantly between the two groups. The reduction in plasma fibrinogen concentration seems of special interest because this variable in several recent studies emerges as a separate cardiovascular risk factor with a high predictive value.


This article has been cited by other articles:


Home page
 Am. J. Clin. Nutr.Home page
J. A Lovegrove, S. S Lovegrove, S. V. Lesauvage, L. M Brady, N. Saini, A. M Minihane, and C. M Williams
Moderate fish-oil supplementation reverses low-platelet, long-chain n-3 polyunsaturated fatty acid status and reduces plasma triacylglycerol concentrations in British Indo-Asians
Am. J. Clinical Nutrition, June 1, 2004; 79(6): 974 - 982.
[Abstract] [Full Text] [PDF]

Home page
 Family and Consumer Sciences Research JournalHome page
E. D. Schlenker
The Evolution of Research in Family and Consumer Sciences: Food, Nutrition, and Health
Family and Consumer Sciences Research Journal, December 1, 2001; 30(2): 140 - 196.
[Abstract] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
E. Dewailly, C. Blanchet, S. Lemieux, L. Sauve, S. Gingras, P. Ayotte, and B. J. Holub
n-3 Fatty acids and cardiovascular disease risk factors among the Inuit of Nunavik
Am. J. Clinical Nutrition, October 1, 2001; 74(4): 464 - 473.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
R. De Caterina and G. Basta
n-3 Fatty acids and the inflammatory response -- biological background
Eur. Heart J. Suppl., June 1, 2001; 3(suppl_D): D42 - D49.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by The American Society for Nutrition